Chemoinformaics analysis of 1,2,3,4,5,6-HEXAMETHOXYXANTHEN-9-ONE
Molecular Weight | 376.361 | nRot | 6 |
Heavy Atom Molecular Weight | 356.201 | nRig | 17 |
Exact Molecular Weight | 376.116 | nRing | 3 |
Solubility: LogS | -3.499 | nHRing | 1 |
Solubility: LogP | 2.346 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 8 | No. of Arom Bond | 16 |
nHA | 8 | APOL | 51.4819 |
nHD | 0 | BPOL | 33.0841 |
QED | 0.607 |
Synth | 2.555 |
Natural Product Likeliness | 1.016 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.997 |
Pgp-sub | 0 |
HIA | 0.027 |
CACO-2 | -4.591 |
MDCK | 0.0000222 |
BBB | 0.168 |
PPB | 0.676215 |
VDSS | 1.047 |
FU | 0.420579 |
CYP1A2-inh | 0.171 |
CYP1A2-sub | 0.993 |
CYP2c19-inh | 0.341 |
CYP2c19-sub | 0.922 |
CYP2c9-inh | 0.266 |
CYP2c9-sub | 0.904 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.865 |
CYP3a4-inh | 0.361 |
CYP3a4-sub | 0.863 |
CL | 3.161 |
T12 | 0.411 |
hERG | 0.141 |
Ames | 0.272 |
ROA | 0.679 |
SkinSen | 0.551 |
Carcinogencity | 0.113 |
EI | 0.167 |
Respiratory | 0.16 |
NR-Aromatase | 0.87 |
Antiviral | Yes |
Prediction | 0.707831 |